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A B S T R A C T
Mycoplasma bovis infections are responsible for substantial economic losses in the cattle industry, have sig-
niﬁcant welfare eﬀects and increase antibiotic use. The pathogen is often introduced into naive herds through
healthy carrier animals.
In countries with a low prevalence of M. bovis, transmission from less common sources can be better explored
as the pathogen has limited circulation compared to high prevalence populations. In this study, we describe how
M. bovis was introduced into two closed and adequately biosecure dairy herds through the use of contaminated
semen during artiﬁcial insemination (AI), leading to mastitis outbreak in both herds. Epidemiological analysis
did not reveal an infection source other than semen. In both farms the primary clinical cases were M. bovis
mastitis in cows inseminated with the semen of the same bull four weeks before the onset of the disease. One
semen straw derived from the semen tank on the farm and other semen lots of this bull were positive forM. bovis.
In contrast, semen samples were negative from other bulls that had been used for insemination in previous or
later oestrus to those cows with M. bovis mastitis. Furthermore, cgMLST of M. bovis isolates supported the
epidemiological results. To our knowledge this is the ﬁrst study describing the introduction of M. bovis infection
into a naive dairy herd via processed semen. The antibiotics used in semen extenders should be re-evaluated in
order to provide farms with M. bovis-free semen or tested M. bovis-free semen should be available.
1. Introduction
Mycoplasma bovis infection causes substantial economic losses and
welfare eﬀects in the cattle industry (Nicholas and Ayling, 2003) and
increases the use of antibiotics. The infection presents a variety of signs,
the most common being respiratory disease, mastitis and joint infec-
tions. (Byrne et al. 2001). The prevalence of M. bovis varies in diﬀerent
countries and areas.
Animal contact is the main source of M. bovis infection. The major
risks for infection are related to animal movement, animal purchase and
animal fairs (Amram et al. 2013; Aebi et al. 2015). Other well known
risks include artiﬁcial insemination (AI) (Wrathall et al. 2007), embryo
transfer (Bielanski et al. 2000), contaminated equipment and environ-
ment (Piccinini et al. 2015), airborne transmission (Jasper et al., 1974)
and contact with infected people (Madoﬀ et al. 1979) or other animal
species (Dyer et al. 2004; Ongor et al. 2008; Spergser et al., 2013).
A reproductive challenge study was able to induce M. bovis
intramammary infection in nine cows following intra-amniotic or intra-
arterial inoculation (Ruben, 1980). Mycoplasma bovis has been isolated
in commercial semen (Amram et al. 2013), withM. bovis positive semen
reported to cause alterations in the fertilization process leading to in-
fertility (Eaglesome and Garcia, 1990) and pathological alterations in
the reproductive organs after experimental intrauterine challenge
(Hartman et al. 1964).
In countries with a low prevalence of M. bovis, transmission from
less common sources can be better explored as the pathogen has limited
circulation compared to high prevalence populations. Mycoplasma bovis
was detected for the ﬁrst time in Finland at the end of 2012 and has
since spread among dairy herds. It has since been monitored because it
is of national interest to control the infection. In this study, we describe
how M. bovis was introduced into two closed and adequately biosecure
dairy herds through the use of contaminated semen during artiﬁcial
insemination (AI), leading to mastitis outbreak in both herds. As far as
we know, our study is the ﬁrst to demonstrate that semen used in AI can
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T
be the initial source of M. bovis infection on a farm.
2. Material and methods
2.1. Surveillance of M. bovis in Finland
M. bovis was detected in Finland for the ﬁrst time in November 2012
in deep nasopharyngeal samples from pneumonic calves in a calf
rearing farm. The calves in this rearing unit originate from several dairy
farms. The infection was indicated to be recent. Mycoplasma bovis was
not detected in a research project on bovine respiratory disease in calf-
rearing units in 2002–2003 (Autio et al. 2007). Since 2003, suspected
cases, such as indicated by respiratory disease and aborted fetuses, have
been examined for M. bovis using culture and PCR. Mastitis pathogen
testing of individual milk samples from clinical and subclinical mastitis
has a long tradition in Finland. Roughly 150 000 samples were tested in
2015 (285 000 cows in Finland in 2015). Since early 2012, almost all
mastitis diagnostic laboratories use multiplex PCR tests that target also
M. bovis (Thermo Scientiﬁc PathoProof Mastitis Complete-16 assay,
Thermo Fisher Scientiﬁc Ltd.). Practicing veterinarians have to report
all M. bovis cases monthly to animal disease control authorities. During
2012–2015, altogether 20 Finnish dairy farms were infected with M.
bovis, which represented 0.26% of all 7 600 Finnish dairy farms in
2015.
Since 2013 the organization Animal Health ETT maintains a vo-
luntary M. bovis control program for cattle farms. The program includes
regular veterinary health care visits, restricted animal movement, sur-
veillance of signs and laboratory examination of subclinical and clinical
mastitis samples with PCR and nasal swabs from calves. The data are
entered into a centralized health care register (Naseva) for cattle herds.
The register includes production data, health records and veterinary
treatments. A total of 75% of all dairy farms belonged to the health
register in 2017 (Animal Health ETT, personal communication).
2.2. Farms in the study
Farmers from 20 newly infected M. bovis dairy farms were inter-
viewed and their herds were sampled. Epidemiological data were col-
lected to assess the infection source. In two concurrently infected farms
the epidemiological data did not suggest a typical infection source and
the farms (X and Y) were investigated in more detail.
2.3. Herd data collection
Herd data were collected using the centralized health care register
and by use of a questionnaire. A project veterinarian visited both farms
twice. Information gathered from the registers included the number of
cattle and cows, milk yield, mortality rate, treatments, dates of M. bovis
mastitis, the number of cattle slaughtered, meat rejected, the number of
milk samples, numbers of purchased and imported cattle, milk-re-
cording system and laboratory results of nasal swab analyses related to
the M. bovis control program.
Information gathered from the farmers included the housing type,
milking system, bedding material, cattle movements, contract heifer
rearing unit, imported or domestic embryos, health care visits, pro-
tective clothing, loading area, corporate truck, equipment of the hoof
trimmer and AMS (automatic milking system) maintenance, vermin and
bird control, the number of cattle slaughtered, meat rejected and par-
ticipation in the M. bovis control program.
Distance to the closest cattle farm was determined from a national
register. Insemination data (dates, bulls and lots) was gathered from the
Finnish Animal Breeding Association (FABA).
2.4. Samples
We examined 98 deep-frozen semen straws, representing 32 lots
from ten bulls (A–J) used in AI in herds X and Y. Four semen straws
were taken from the liquid nitrogen tank from farm X, and the rest were
obtained from the breeding company. The straws examined belonged
either to the same lot used in the herds or the closest lot available.
Semen from bull A was collected and handled at a semen collection
center and was examined according to OIE requirements. Collection of
semen started at the age of 11 months. Based on the results of semen
samples, conjunctival swabs, nasal swabs, preputial swabs
(Transsystem, Copan Brescia, Italy), pre-ejaculate and semen samples
were taken from the bull A at the age of 2 years 4 months. Pre-ejaculate
and semen were placed in F-broth for mycoplasma culture.
A total of 15 and 20 calves were sampled on farms X and Y, re-
spectively, 4 to 5 weeks after the primary infection. Nasal swabs
(Transsystem) were collected from calves 1 week to 6 months old.
2.5. Culture of M. bovis
The straws (n=58) were thawed in 37 °C water bath. Semen from
the straw was inoculated in a tube containing 2.7 ml F broth prepared
according to Bölske (1988). Inoculated F broth was diluted 10-fold up
to 10−6 and incubated at 37 °C for 14 days. The growth and color
change were monitored every other day, and samples suspected of
containing mycoplasma were subcultured onto F-medium plates
(Bölske, 1988). Plates were incubated at 5% CO2, 37 °C for seven days,
and inspected every second day under the microscope for mycoplasma
growth. Mycoplasma bovis was identiﬁed using PCR.
2.6. DNA extraction and Mycoplasma bovis real time PCR
DNA was extracted from semen straws (n= 40) using a QIAamp
Mini Kit (Qiagen, Hilden, German), following the manufacturer’s pro-
tocol for blood and body ﬂuids. DNA was eluted from the spin column
with 50 μl of water. The protocols described by Sachse et al. (2010)
were used for nasal swabs and broth cultures.
Semen, nasal swabs and broth cultures were examined using real
time PCR targeting the oppD gene of M. bovis (CFX96 Touch Real-Time
PCR Detection System, Bio-Rad Laboratories, CA, USA) as described
previously (Sachse et al. 2010). Commercially available plasmid pUC19
was used as the internal ampliﬁcation control according to Fricker et al.
(2007), except that BHQ1 was used instead of TAMRA in the probe.
2.7. Whole genome sequencing
Whole Genome Sequencing (WGS) was used to compare genomes. A
total of 11 M. bovis isolates were included in the study (Table 1): the
isolate 11911 from the ﬁrst mastitis case on farm X, the isolate 13775
from the ﬁrst mastitis case on farm Y, the isolate 198 from semen lot 3
from bull A, seven isolates obtained from diseased cattle in Finland
during 2012–2015, and one isolate from a pneumonic calf in Estonia.
The isolates were selected to represent various herd types, clinical
presentations and geographical distribution within Finland, including
isolates from the ﬁrst two M. bovis cases in Finland.
All isolates were puriﬁed three times before freezing and were
stored in F-broth medium (Bölske, 1988) at −80 °C. For DNA extrac-
tion, the isolates were grown in 50ml F-broth in closed tubes at 37 °C
for 90 h. The bacteria were spun down at +4 °C, 19,800 g, for 30min.
The pellets were washed with sterile PBS and spun down again. The
pellets were resuspended in 180 μl of sterile PBS. DNA was extracted
using a QIAamp Mini Kit, following the manufacturer’s protocol for
blood and body ﬂuids. DNA concentration was measured (Qubit dsDNA
BR assay system, Invitrogen, Carlsdab, CA) and quality assessed in 0.8%
gel electrophoresis.
WGS was done at the Danish Technical University, Department for
Biotechnology and Biomedicine, Lyngby, Denmark. A Nextera XT kit
(Illumina, San Diego, CA) was used according to the manufacturer’s
instructions to prepare the libraries for WGS. An Illumina MiSeq
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(Illumina) platform with 300 base paired-end sequencing was used.
2.8. Core genome MLST analysis
De novo assembly of the sequencing reads was performed using
Velvet assembler version 1.1.04 (Zerbino and Birney, 2008) of Ridom
SeqSphere+ (Ridom GmbH, Münster, Germany) software (Jünemann
et al. 2013). Automated k-mer and coverage cutoﬀ optimizations were
performed for each assembly.
The BLAST-based target deﬁner function (Altschul et al. 1990) of
the Ridom SeqSphere+ software was operated to identify 527 core
genome and 168 accessory genome target loci from the reference strain
NC_014760.1 (M. bovis PG 45) and seven complete query genomes
obtained from GenBank (NZ_CP005933.1, NC_018077.1, NC_015725.1,
NZ_CP011348.1, NZ_CP007589.1, NZ_CP007590.1 and
NZ_CP007591.1). A minimum spanning tree (MST) within the Ridom
SeqSphere+ software was constructed to visualize the results.
3. Results
3.1. Farm data
Both farms were loose house dairy farms with good farming practice
(Table 2) and good or excellent biosecurity (Table 3). In both farms
milk samples from clinical mastitis, high somatic cell count (SCC)
quarters and before drying oﬀ, were regularly monitored for pathogens,
including M. bovis. Farm Y belonged to the M. bovis control program
and had been sampled twice for M. bovis with negative results in 2013
and 2014. Our epidemiological analysis did not ﬁnd any signiﬁcant
route of infection other than semen (Table 3).
Mycoplasma bovis was diagnosed for the ﬁrst time in both farms
from quarter milk samples with clinical mastitis. Starting in November
2015, farm X had four M. bovis mastitis cases within ﬁve weeks (Fig. 1).
Farm Y had threeM. bovismastitis cases within four weeks, the ﬁrst one
in December 2015 (Fig. 2). There were no previous signs at either farm
and the levels of medical treatment were normal. Mycoplasma bovis was
detected from calves in both farms 4–5 weeks after the primary case.
Altogether four cows in these herds had been inseminated with semen
from which M. bovis was isolated. All but one of the cows developed M.
bovis mastitis.
3.2. Mycoplasma bovis in semen and bull samples
Altogether ten bulls (A–J) were used to inseminate cows that de-
veloped M. bovis mastitis. One of them (bull A) had M. bovis-positive
semen lots (Table 4). Of the 22 examined semen lots from bull A, lots 4,
Table 1
Description of Mycoplasma bovis isolates sequenced in this study.
Isolate ID Farm type/country Year of isolation Clinical presentation / sample type
10419 calf rearing / FI 2012 respiratory disease / nasopharyngeal swab
10585 dairy / FI 2012 mastitis / milk
9578 dairy / FI 2013 mastitis / milk
3738 beef cattle / FI 2013 respiratory disease / lung
7818 dairy / FI 2014 mastitis / milk
6414 dairy / FI 2014 arthritis / joint ﬂuid
16981 calf rearing / FI 2014 respiratory disease / nasopharyngeal swab
119111a dairy / FI 2015 mastitis / milk
198b bull station / DK 2015 clinically healthy / semen
13775c dairy / FI 2015 mastitis / milk
537 dairy / EE 2011 respiratory disease / tracheobronchial lavage
FI= Finland, DK=Denmark, EE=Estonia.
a Farm X.
b Bull A used in Farm X and Y.
c Farm Y.
Table 2
Description of farms X and Y in 2015.
Farm description Farm X Farm Y
No. of animals 139 126
No. of cows 60 61
Housing type Loose house Loose house
Milking system AMSa AMS
Ave. milk yield in the herd (kg) 9561 9984
Bedding material
Calves Peat moss Straw
Cows Sawdust Sawdust
Veterinary health care visits in 2015 6 12
Mortality rate in 2015 0.7 % 3.25 %
Related signs treated in 2015 (no. of cases
before primary case)
Mastitis other than M. bovis 7 8
Arthritis 1 0
Respiratory signs with young stock 1 3
No. of animals slaughtered / meat rejected 28 / 7 kg 13 / 0 kg
Finnish milk-recording system Yes Yes
Centralized health care register of cattle Yes Yes




No. of milk samples examined forM. bovis in
2015 before primary case
41 200
a Automatic milking system.
Table 3
External biosecurity activities related to M. bovis introduction to the farms.
External biosecurity risk factors Farm X Farm Y
Last purchase of cattle 2011 2003
Cattle movements (e.g. animal fairs) None None
Contract heifer rearing unit No No
Imported cattle None None
Imported embryosa None None
Domestic embryosa Yes Yes
Protective clothing and footwear Yesb Yes
Separate loading area No Yes
Uses a corporate truck to move own animals No No
M. bovis control program No Yes
Distance to known M. bovis-positive farm 87 km 87 km
Hoof trimmer, equipment properly cleaned –c Yes
AMSd maintenance, equipment properly cleaned Yes Yes
Vermin and bird control Yes Yes
a Within three years before the primary case.
b Before 2011, the driver of slaughter animals and calves has rarely been inside the
barn with own gear and veterinarian has used own protective gear.
c No corporate trimmer used.
d Automatic milking system.
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6 and 12 were positive following PCR analysis and lots 3 and 4 were
positive in culture (Table 5). All mucosal swabs as well as pre-ejaculate
and sperm samples taken from bull A at the age of 2 years were negative
for M. bovis following PCR or culture.
3.3. Core genome MLST analysis
The core-genome multilocus sequence typing (cgMLST) schema
targets covered 58.2% of the reference genome. From the 11 isolates
selected for this study, 589 cgMLST allele-called targets were extracted
and compared with each other. Except for the Estonian strain 537, all
other isolates clustered together within a 4–24 allele diﬀerence. The
mastitis strains from farms X and Y and the bull A semen strain had
allele diﬀerences of 4 and 8, respectively, and clustered together
(Fig. 3).
4. Discussion
To our knowledge this is the ﬁrst study to describe the introduction
of M. bovis infection into a naive herd via processed semen.
Epidemiological analysis did not establish any source other than M.
bovis-contaminated processed semen used for insemination. It was
possible to identify this rare incidence in a country where both M. bovis
prevalence and cattle density are low. In both farms the primary clinical
cases were mastitis caused by M. bovis in cows that had been in-
seminated with the semen from the same bull four weeks before the
onset of the disease. The semen originating from the liquid nitrogen
tank from farm X, as well as some other lots of semen from this bull,
were positive for M. bovis. In contrast, semen samples were negative
from other bulls that had been used for insemination in previous or
later oestrus to those cows with M. bovis mastitis. Furthermore, cgMLST
supported the epidemiological results. There was a diﬀerence of four
alleles between isolate 198 (semen from bull A) and isolate 11911 (farm
X, mastitis) and eight alleles between isolates 11911 and 13775 (farm
Y, mastitis). These isolates clustered separately from the other Finnish
isolates, although there was limited diversity among the Finnish iso-
lates. The results strongly support the ﬁnding that semen positive forM.
bovis used in insemination was the source of the M. bovis infection.
From all the farm data, we concluded that both farms X and Y were
free of M. bovis infection before the primary mastitis cases. Farm Y had
reached the low risk level in the voluntary M. bovis control program.
Neither farm had purchased live animals during the last four years, nor
did they use contract heifer rearing or attend cattle shows with their
animals. Both farms were situated in an area of low cattle density.
Mastitis samples had been regularly examined for M. bovis using PCR
with negative results since February 2012.
The most common means of contracting M. bovis by a naive herd is
through purchase of a clinically healthy animal shedding the agent
(Gonzalez et al. 1992; Aebi et al. 2015). Other possible sources include
airborne transmission and fomites. There is no well-founded evidence
for airborne transmission of M. bovis. Soehnlen et al. (2012) analyzed
M. bovis content of the air of veal calf barns monthly and no M. bovis
was detected, although 90.5% of the calves were colonized nasally and
40% bronchially. Only one previous report exists of M. bovis being
Fig. 1. Course in M. bovis infection in herd X. NS, nasal swabs of calves, positive/total examined for M. bovis.
Fig. 2. Course in M. bovis infection in herd Y. NS, nasal swabs of calves, positive/total examined for M. bovis.
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successfully cultivated from the air by leaving an agar plate open in the
barn housing calves with M. bovis associated disease (Jasper et al.,
1974). Otake et al. (2010) describes airborne transmission of Myco-
plasma hyopneumoniae from a population of growing pigs with experi-
mental infection. Mycoplasma hyopneumoniae was recovered in 5.3% of
air samples taken within 3.5–9.2 km of the source, and was shown to
retain infectiousness. This suggests that during an outbreak under fa-
vorable weather conditions, airborne transmission might be possible.
Barn ventilation, stocking density and pen design inﬂuence airborne
transmission of mycoplasmas. Although environment and management
diﬀer between cattle and pig farms, results from M. hyopneumoniae air
transmission studies might be applicable to M. bovis. In this study air-
borne transmission was most unlikely because the closest known M.
bovis-positive farms were far apart (87 km).
Experimental inoculation of bulls´ preputium or urethra with M.
bovis can produce ascending infection of the testes and shedding of M.
bovis into semen (Kreusel et al. 1989). Diﬀerent mycoplasmas can co-
lonize the prepuce and distal urethra of normal AI bulls and can also be
isolated from semen (Doig, 1981; Onoviran et al. 1975; Parker et al.
2017). In our study, bull A shed M. bovis in semen for only a short
period (seven weeks intermittently, and testing for carrier status was
negative 17 months after semen collection started). The impact of M.
bovis positive bull in transmission of the infection is unknown. Only few
semen lots from bull A, and not all straws from these lots, tested po-
sitive. The high Ct values indicated low levels of the pathogen in the
positive straws. Mycoplasma bovis growth was observed only in a 10−3
dilution. This suggests that the extender antibiotics have only a bac-
teriostatic but not a bactericidal eﬀect. With bacteriostatic eﬀect, it still
has the potential to replicate and cause disease under the right condi-
tions.
Several types of antibiotic have been added to seminal extenders
before freezing to control bacterial contamination in semen. European
Union (EU) directive 88/407 (EC, 1993) sets out the volume of anti-
biotics to be added to extended semen as follows: 500 IU per ml
streptomycin, 500 IU per ml penicillin, 150 μg per ml lincomycin and
300 μg per ml spectinomycin. A so-termed GTLS mixture containing
500 μg gentamycin, 100 μg tylosin, 300 μg lincomycin and 600 μg
spectinomycin per ml of extender without glycerol was developed by
Shin et al. (1988) and is shown to be more eﬃcient against myco-
plasmas than a penicillin-streptomycin-polymyxin B combination.
However, a later study by Visser et al. (1999) showed that a GTLS
antibiotic combination has a bacteriostatic but not a bactericidal eﬀect
on diﬀerent M. bovis strains used in vitro to contaminate semen. Re-
cently Gloria et al. (2014) showed that a GTLS mixture failed to elim-
inate bacteria in frozen-thawed semen of one bull out of ten examined.
Because mycoplasmas lack a cell wall they are intrinsically resistant to
ß-lactam antibiotics. Several authors have reported an increase in the
minimum inhibition concentrations (MIC) against several antimicrobial
groups in European M. bovis isolates (Ayling et al. 2014; Gautier-
Bouchardon et al. 2014; Heuvelink et al. 2016). In some of the studies
Table 4
Occurrence of M. bovis mastitis in farms where M. bovis contaminated semen of bull A was used.
Farm Cow M. bovis mastitis diagnosed (PCR) Insemination date Insemination No. Bull used M. bovis status of the semen
X 1 5.10.2015 1 A positive
X 1 7.11.2015 30.10.2015 2 A positive
X 2 26.8.2015 1 B negativeb
X 2 2.7.2015 2 B negative
X 2 17.9.2015 3 C negative
X 2 8.10.2015 4 A positive
X 2 22.11.2015 1.11.2015 5 D negative
X 3 22.11.2015 22.8.2015 1 E negativeb
X 4 8.10.2015 1 F negativeb
X 4 28.10.2015 2 F negative
X 4 11.12.2015 30.10.2015 3 F negativeb
Y 5 20.9.2015 1 G negativeb
Y 5 23.9.2015 2 G negativeb
Y 5 13.10.2015 3 G negativeb
Y 5 5.11.2015 4 A positive
Y 5 8.12.2015 29.11.2015 5 H negative
Y 6 23.11.2015a 1
Y 6 5.1.2016 29.12.2015 2 I negative
Y 7 8.11.2015 1 F negative
Y 7 8.1.2016 29.12.2015 2 J negative
a Embryo transfer.
b Result from closest lot available of the lot used in AI.
Table 5


















1 20.4.2015 2 0/1 ndb 0/1
2 4.5.2015 2 0/1 nd 0/1
3 11.5.2015 5 0/2 nd 2c/3
4 20.5.2015 4 1/2 35.11 2c/2
5 27.5.2015 2 0/1 nd 0/1
6 8.6.2015 10 2/3 36.6/35.4 0/7
7 15.6.2015 2 0/1 nd 0/1
8 17.6.2015 3 0/1 nd 0/2
9 naa
10 22.6.2015 2 0/1 nd 0/1
11 26.6.2015 2 0/1 nd 0/1
12 1.7.2015 10 1/3 37.5 0/7
13 3.7.2015 2 0/1 nd 0/1
14 6.7.2015 2 0/1 nd 0/1
15 20.7.2015 4 0/2 nd 0/2
16 29.7.2015 9 0/2 nd 0/7
17 31.7.2015 2 0/1 nd 0/1
18 26.8.2015 2 0/1 nd 0/1
19 31.8.2015 2 0/1 nd 0/1
20 2.9.2015 2 0/1 nd 0/1
21 9.9.2015 2 0/1 nd 0/1
22 na
23 18.9.2015 2 0/1 nd 0/1
24 23.9.2015 2 0/1 nd 0/1
a Not available.
b Not detected.
c M. bovis growth only in 10−3 dilution.
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MIC values against tylosin and lincomycin / spectinomycin were quite
high, thus the antibiotics used in semen extenders should be re-eval-
uated to ensureM. bovis-free semen or testedM. bovis-free semen should
be available.
Several methods, mainly MLST and MLVA, have been used to gen-
otype M. bovis. Molecular epidemiological studies report loss of di-
versity withinM. bovis isolates over recent decades (Becker et al. 2015).
Lately more detailed WGS-based methods targeting the whole genome
are applied in characterization of mycoplasmas in epidemiological
studies (Diaz et al. 2017), but only one conduct on M. bovis (Parker
et al. 2016). Using whole genome SNP analysis, Parker et al. (2016)
showed limited diversity among Australian M. bovis strains: there was a
maximum of 50 SNP diﬀerence among 75 isolates collected during
eight years. Similarly in our core genome MLST analysis, the Finnish
strains isolated during four years clustered together and apart from an
Estonian strain, indicating limited diversity among Finnish strains.
5. Conclusion
Our results indicate that M. bovis-positive semen used in insemina-
tion was the source of infection in two dairy farms, causing M. bovis
mastitis. The infection source was identiﬁed by epidemiological ana-
lysis and cgMLST analysis ofM. bovis isolates. Even though introduction
of M. bovis into a herd via semen appears to be rare, semen has to be
taken into account as a source of infection, and precautions need to be
taken, especially in areas free of M. bovis, as well as in high-biosecurity
herds. Global trade in semen may spread M. bovis to a new country or
area. The antibiotics used in semen extenders should be re-evaluated to
obtain M. bovis-free semen or tested M. bovis-free semen should be
available.
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